Literature DB >> 655114

Effects of verapamil on ventricular rhythm during acute coronary occlusion.

J D Fondacaro, J Han, M S Yoon.   

Abstract

The effects of verapamil on electrophysiologic parameters of the ventricle were studied during acute coronary occlusion in anesthetized open-chest dogs. Those parameters measured in the study were idioventricular automaticity, ventricular conduction, and fibrillation threshold. The incidence of rapidly repetitive beats and fibrillation induced by two successive premature beats was also studied. Verapamil significantly decreased idioventricular automaticity (in five dogs), improved conduction through the ischemic area (in six dogs), and increased fibrillation threshold of the ischemic ventricular (in eight dogs). The drug was effective in abolishing rapidly repetitive beats and fibrillation induced by closely coupled premature beats during acute coronary occlusion. Rapidly repetitive beats occurred in nine out of 15 dogs and these repetitive beats were degenerated into fibrillation in seven dogs before verapamil. Following pretreatment with the drug, rapidly repetitive beats and fibrillation occurred in none of the 15 dogs. The results indicate that verapamil can be very effective against ventricular arrhythmias occurring in association with myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655114     DOI: 10.1016/0002-8703(78)90129-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Effects of blockade of fast and slow inward current channels on ventricular fibrillation in the pig heart.

Authors:  A J Stewart; J D Allen; A B Devine; A A Adgey
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

2.  Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.

Authors:  Q Timour; B Bui-Xuan; G Faucon; J F Aupetit
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  Calcium channel blockers.

Authors:  P C Deedwania
Journal:  West J Med       Date:  1982-07

4.  Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.

Authors:  M J Curtis; B A MacLeod; M J Walker
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

5.  Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.

Authors:  H Gülker; W Haverkamp; G Hindricks; F Bender
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

6.  Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.

Authors:  A M Lefer; E W Polansky; C P Bianchi; S Narayan
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

Review 7.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

8.  Effect of verapamil and diltiazem on calcium-dependent electrical activity in cardiac Purkinje fibres.

Authors:  S Amerini; A Giotti; A Mugelli
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

9.  Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.

Authors:  J F Aupetit; Q Timour; G Chevrel; J Loufoua-Moundanga; S Omar; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

10.  L-Type Calcium Channels Do Not Play a Critical Role in Chest Blow Induced Ventricular Fibrillation: Commotio Cordis.

Authors:  Christopher Madias; Ann C Garlitski; John Kalin; Mark S Link
Journal:  Cardiol Res Pract       Date:  2016-01-26       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.